Dr. Trogele brings decades of global agribusiness leadership to the EcoPhage board, having held senior roles at major ...

Armata Pharma reports positive data from phase 1b/2a diSArm study of intravenously administered AP-SA02 to treat S. aureus bacteremia: Los Angeles Tuesday, May 20, 2025, 17:00 Hrs ...

BiomX announced positive topline results of the phase 2 trial evaluating BX211 for the treatment of diabetic foot osteomyelitis (DFO)< ...

Biofilm formation by Streptococcus pneumoniae ... (2) It would be interesting to analyze the link to phage infection and heat stress in relation to Quorum. The authors could study QS regulators or AI2 ...

A biofilm forms when bacteria cling to a surface ... That’s why Norgen is here to support you every step of the way. Phage therapy offers a promising alternative to antibiotics in the fight ...

To treat her, the SGH team used phage therapy in combination with antibiotics. While it was difficult for antibiotics to reach the culprit bacteria that were shielded in biofilm, phages were ...

Research has been conducted on the effects of phages and their individual proteins to assess their potential for biofilm removal. However, challenges persist, prompting the examination of refined ...

While there are not yet any phage products licensed as human medicines ... Phages have evolved the ability to actively penetrate biofilms (communities of bacteria encased in a protective matrix ...

But phage therapy soon faded in importance ... therapeutic capabilities such as expanded host ranges and improved anti-biofilm activities. Such phages are better able to overcome bacterial ...

Recognizing the specificity of phage therapy and its ability to spare beneficial bacteria ... faecalis and effectively lysed biofilms. Notably, the endolysin’s lytic activity did not affect other ...